Methods of treating pancytopenia and AIDS by co-administering EP

Details Methods of treating pancytopenia and AIDS by co-administering EP Methods of treating pancytopenia and AIDS by co-administering EP

1989-11-07

1993-03-30

Stone, Jacqueline

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 8, 514885, A61K 3702

Patent

active

051984172

ABSTRACT:
Disclosed herein is the treatment of patients suffering from AIDS-type disease with erythropoietin alone or together with a colony stimulating factor, and/or an anti-viral agent and/or IL-2.

REFERENCES:
patent: 4230697 (1980-10-01), Nishida et al.
Motoyoshi et al, Chem. Abstracts, vol. 99:1046a (1982).
Rook et al, J. Immunol., vol. 134, No. 3, (1985), pp. 1503-1507.
Kern et al, Biol. Abstracts, vol. 79(11), No. 100547 (1985).
Spivak et al, Biol. Abstracts vol. 78(12), No. 92073, 1984.
Metcalf et al, Chem. Abstracts, vol. 91:49943c (1979).
Migliaccio, Blood 72(3): 944-41(1988).
Umemura, Blood 73(7):1993-98(1989).
Krumwieh, J. Cell Biotech. 13(supp): 51a, H407(1989).
Miles, Abstracts from V Int'l Conf. on AIDS, Abstract MCP52, P550(1989).
Mitsuyasu, Biotherapy 2: 173-81(1990).

Affiliated with

Also associated with

Rating

Methods of treating pancytopenia and AIDS by co-administering EP does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating pancytopenia and AIDS by co-administering EP, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating pancytopenia and AIDS by co-administering EP will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1281068